Filter
1140
Filtered Results: 1140
Text search:
therapeutic
agents
Featured
Recommendations
145
New Publications
286
Language
Document type
No document type
560
Guidelines
256
Studies & Reports
189
Manuals
62
Strategic & Response Plan
24
Fact sheets
17
Training Material
16
Situation Updates
9
Brochures
2
Resource Platforms
2
Infographics
2
Online Courses
1
Countries / Regions
India
76
South Africa
46
Global
41
Kenya
37
Ethiopia
27
Uganda
21
Nigeria
20
Zambia
19
Tanzania
19
Latin America and the Carribbean
17
Nepal
16
Western and Central Europe
16
Sierra Leone
15
Bangladesh
15
Liberia
13
Ghana
12
Rwanda
12
Philippines
11
Namibia
11
Myanmar / Burma
10
Congo, Democratic Republic of
9
Africa
8
Burkina Faso
7
Cambodia
7
Mozambique
7
Russia
7
Germany
6
Malawi
6
Brazil
6
Lesotho
6
USA
5
Cameroon
5
Zimbabwe
5
Indonesia
5
Ukraine
5
Guinea
4
Senegal
4
Mali
4
Haiti
4
Syria
4
Thailand
4
Benin
4
West and Central Africa
4
Middle East and North Africa
4
Eastern Europe
4
Eswatini/ Swaziland
3
North Macedonia
3
Yemen
3
East and Southern Africa
3
South–East Asia Region
3
Eastern Europe and Central Asia
3
Asia
3
Venezuela
3
Vietnam
3
France
3
Spain
3
Pakistan
2
South Sudan
2
Iraq
2
Afghanistan
2
China
2
Sudan
2
Botswana
2
Libya
2
Angola
2
Madagascar
2
Western Pacific Region
2
Paraguay
2
Fiji
2
Bhutan
2
Laos
2
Tajikistan
2
Georgia
2
Gabon
2
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Niger
1
Somalia
1
Jordan
1
Turkey
1
Malaysia
1
Singapore
1
Papua New Guinea
1
Central African Republic
1
Argentina
1
Peru
1
Serbia
1
Colombia
1
Sri Lanka
1
Other region
1
Solomon Islands
1
Albania
1
Armenia
1
Congo-Brazzaville
1
Estonia
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
North America
1
Turkmenistan
1
Denmark
1
Maldives
1
Mauritius
1
United Kingdom
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
442
Clinical Guidelines
171
Public Health
58
Women & Child Health
46
Key Resources
33
Pharmacy & Technologies
18
Capacity Building
12
Toolboxes
AMR
167
COVID-19
82
Mental Health
79
Pharmacy
78
HIV
61
TB
58
NCDs
37
Ebola
36
Caregiver
32
NTDs
32
Rapid Response
31
Planetary Health
16
Disability
12
Refugee
12
Conflict
9
Natural Hazards
8
Specific Hazards
7
Cholera
5
Global Health Education
4
Zika
3
Polio
2
Social Ethics
2
Health Financing Toolbox
2
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatr...
The potential for terrorist use of chemical agents is a noted concern highlighted by the Tokyo sarin gas attacks of 1995. The events of September 11, 2001, increased congressional attention towards reducing the vulnerability of the United States to ...
Dermatological Preparations For The Tropics
recommended
A formulary of dermatological preparations and background information on therapeutic choices, production and dispensing. 2nd edition
6th edition, The NLEM 2021 contains 398 drugs molecules in different therapeutic categories.
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing h...
During the COVID-19 health crisis, community pharmacists had an enhanced role in supporting health-care systems that were overburdened by managing seriously ill patients. This study was undertaken to determine the patterns of community supply of antiviral and antibacterial ... from community pharmacies during the COVID-19 pandemic in selected countries in eastern Europe and central Asia. Nine countries – Armenia, Georgia, Kazakhstan, Kyrgyzstan, North Macedonia, the Russian Federation, Serbia, Tajikistan and Uzbekistan – participated in this cross-sectional study.
The publication of the Second Edition of the Emergency Drug Guidelines represents the culmination of the efforts of the National Drugs and Therapeutics Committee (NDTC) to publish clinical drug guidelines for common diseases seen in Fiji. These guid...
This National Action Plan addresses actions needed to be taken in order to combat antimicrobial resistance (AMR) in the country. It is obligatory to raise awareness of antimicrobial resistance and promote behavioral change through public communication
programmes that targets human, animal and plant...
China is one of the major countries for the production and use of antibacterial agents. Antibacterial agents are widely used in healthcare and animal husbandry. It plays a significant role in treati...
MSF Essential Drugs - Practical Guidelines 2022
recommended
Practical guide intended for physicians, pharmacists, nurses and medical auxiliaries. This guide is not a dictionary of pharmacological agents. It is a practical manual intended for health professionals, physicians, pharmacists, nurses and health au...
This document provides additional guidance for the responsible and prudent use of antimicrobials in food-producing animals, and should be read in conjunction with the Recommended International Code of Practice for Control of the Use of Veterinary Drugs CAC/RCP 38-1993. Its objectives are to minimize...
Antimicrobial resistance (AMR) is a major global public health concern and a food safety issue. When pathogens become resistant to antimicrobial agents they can pose a greater human health risk as a result of potential treatment failure, loss of tr...
Textes du Codex concernant la résistance aux antimicrobiens d’origine alimentaire
Textos del Codex sobre la resistencia a los antimicrobianos transmitida por los alimentos
Antimicrobial resistance (AMR) is a major global public health concern and a food safety issue. When pathogens become r...
This document provides additional guidance for the responsible and prudent use of antimicrobials in food-producing animals, and should be read in conjunction with the Recommended International Code of Practice for Control of the Use of Veterinary Drugs CAC/RCP 38-1993. Its obj...
Nosocomial infections, or hospital-acquired infec-tions (HAI), are among the most significant causesof morbidity and mortality in healthcare settingsthroughout the world.Prevention of HAIs iscentral to providing high quality and safe health-care, even in settings with limited resources.Transmi...
The PHC STGs and EML should be used by healthcare workers providing care at clinics, community health centres, and gateway clinics at hospitals.
Pharmaceutical and Therapeutics Committees (PTCs) are responsible for ensuring the availability of medi...
These guidelines are based on the 3rd Edition of the WHO Guidelines (Published 2015) World Health Organization’s Guidelines for the treatment of malaria. Additional literature surveys have been undertaken. Factors that were considered in the choice of th... options included effectiveness, safety, and impact on malaria transmission and on the emergence and spread of antimalarial drug resistance. On-going surveillance is critical given the spread of artemisinin resistance in Southeast Asia, although not yet confirmed anywhere in Africa. The guidelines on the treatment of malaria in South Africa aim to facilitate effective, appropriate and timeous treatment of malaria, thereby reducing the burden of this disease in our communities. This is essential to further reduce the malaria case fatality rates currently recorded in South Africa, to decrease malaria transmission and to limit resistance to antimalarial drugs.
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
Chromoblastomycosis (CMB) is a chronic fungal infection of the skin and the subcutaneous tissue caused by a transcutaneous traumatic inoculation of a specific group of dematiaceous fungi occurring mainly in tropical and subtropical zones worldwide. If not diagnosed at early stages, patients with CBM...
Peripheral artery disease (PAD) is the most underdiagnosed, underestimated and undertreated of the atherosclerotic vascular diseases despite its poor prognosis. There may be racial or contextual differences in the Asia-Pacific region as to epidemiology, availability of diagnostic and ... modalities, and even patient treatment response. The Asian Pacific Society of Atherosclerosis and Vascular Diseases (APSAVD) thus coordinated the development of an Asia-Pacific Consensus Statement (APCS) on the Management of PAD.
